Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic H5N1 Influenza”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Early research (Phase 1)Study completedNCT00356798
What this trial is testing

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 120
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Early research (Phase 1)Study completedNCT00984945
What this trial is testing

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 48
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00519389
What this trial is testing

Safety, Reactogenicity and Immunogenicity of an H5N1 VLP

Who this might be right for
Pandemic Influenza
Novavax 230
Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00734175
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Testing effectiveness (Phase 2)Study completedNCT01776554
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 662
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Early research (Phase 1)Study completedNCT02480101
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

Who this might be right for
Influenza
Research Institute of Influenza, Russia 40
Early research (Phase 1)Study completedNCT00783926
What this trial is testing

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 422
Large-scale testing (Phase 3)Study completedNCT01382329
What this trial is testing

H5N1 Vaccine Study in Japanese Adults

Who this might be right for
H5N1 Influenza
Alachua Government Services, Inc. 340
Testing effectiveness (Phase 2)Study completedNCT00695669
What this trial is testing

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Who this might be right for
Influenza
GlaxoSmithKline 312
Testing effectiveness (Phase 2)Study completedNCT01195038
What this trial is testing

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Who this might be right for
Influenza
UMN Pharma Inc. 87
Not applicableWithdrawnNCT00640874
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Large-scale testing (Phase 3)Study completedNCT02839330
What this trial is testing

Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Who this might be right for
Avian Influenza
Seqirus 3,196
Testing effectiveness (Phase 2)Study completedNCT00530660
What this trial is testing

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Who this might be right for
Influenza
Alachua Government Services, Inc. 141
Testing effectiveness (Phase 2)Study completedNCT00415129
What this trial is testing

Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 600
Load More Results